Clinical studies show reduced p-mTOR/mTOR in DKD (Xiong et al., 2019), while podocyte mTORC1 hyperactivation in obesity CKD exacerbates renal dysfunction (Iwata et al., 2020). This evidence concerns the gene MTOR and diabetic kidney disease.